Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 24Myelodysplastic Syndromes 23Leukemia 23Leukemia, Myelomonocytic, Chronic 18Leukemia, Myeloid, Acute 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Leukemia, Myeloid, Chronic-Phase 16Myeloproliferative Disorders 14Leukemia, Myeloid, Accelerated Phase 14Anemia, Refractory 12Leukemia, Lymphocytic, Chronic, B-Cell 11Congenital Abnormalities 11Blast Crisis 10Myelodysplastic-Myeloproliferative Diseases 9Multiple Myeloma 9Lymphoma, Follicular 9Lymphoma, Large B-Cell, Diffuse 8Lymphoma 8Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 8Hodgkin Disease 8Primary Myelofibrosis 7Lymphoma, Non-Hodgkin 7Lymphoma, Mantle-Cell 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, B-Cell, Marginal Zone 7Burkitt Lymphoma 7Waldenstrom Macroglobulinemia 6Polycythemia Vera 6Neoplasms, Plasma Cell 6Graft vs Host Disease 6

Interventions

eltrombopag 14romiplostim 7avatrombopag 7Platelet Transfusion 6Cytarabine 6Radiotherapy 4Filgrastim 4Etoposide 4Carboplatin 4oprelvekin 3Tranexamic Acid 3Peripheral Blood Stem Cell Transplantation 3Daunorubicin 3Cyclophosphamide 3Busulfan 3hetrombopag 2fludarabine phosphate 2Tretinoin 2Thrombopoietin 2Lenalidomide 2Interleukin-11 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Doxorubicin 2Cyclosporine 2Amplified Fragment Length Polymorphism Analysis 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2sodium thiosulfate 1siltuximab 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytopenia × Methotrexate × Classical hematology × Clear all
NCT00002665 2015-03-06

SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia

SWOG Cancer Research Network

Phase 2 Completed
50 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Leukemia, Neutropenia, Thrombocytopenia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡